Professor of Pharmaceutics Rodney Ho’s new startup, Nova TheraNostics, has developed a brighter, longer lasting and safer MRI contrast agent. It is among 17 companies that the UW launched this fiscal year. Read more in ‘UW Today’ and the ‘Seattle Times.’